A Comparison of Treatment With Skin Graft or Secondary Healing for Nasal Wound Defects After Tumor Excision
- Recon Review
- Apr 29
- 2 min read
Updated: Oct 20
Key take aways:
Secondary healing of small (<3x3 cm) wounds on the tip or ala yields superior cosmetic outcomes compared to FTSG, although time to heal is slightly longer
Background
The treatment strategies for small nasal wound defects post-tumor excision often involve complex decisions regarding cosmetic outcomes and healing duration.
Objective
This study's primary aim was to evaluate the short- and long-term healing outcomes and cosmetic results of using FTSG versus secondary healing in patients with nasal defects post-tumor excision.
Methods

RCT at Linköping University Hospital
Inclusion:
18+ yo
Wound measuring 3x3 cm or smaller on the tip or alae
Max depth: intact perichondrium (i.e. graftable)
Participants randomized to FTSG or secondary healing
Both groups were dressed with PolyMem (hydrophilic polyurethane foam) dressings
Primary outcomes included hand scar quality as assessed by Patient and Observer Scar Assessment Scale (POSAS) :
POSAS performed in short term (1 and 4 weeks) and long term (6 mo)
Results
A total of 30 patients were enrolled, and after exclusions for re-excision or withdrawal, 26 were analyzed.
Median age of participants was 74.5 years, 50% were male.
Healing times presented as median (IQR) were 35.0 days in the secondary healing group (SH) versus 28.0 days in the skin graft group (FTSG), with no statistically significant difference (P = 0.47).
At the 6-month follow-up, the SH group demonstrated superior scores in observer-assessed key parameters: vascularity (P = 0.003), pigmentation (P = 0.007), thickness (P = 0.002), and relief (P = 0.01).
Overall, patient-reported outcomes showed significant satisfaction in the SH group regarding scar aesthetics
Conclusion
While the healing duration was slightly longer for secondary healing, the long-term cosmetic results indicated that this approach may provide superior long-term outcomes compared to skin grafting.
Strengths and Limitations
Strengths include the randomized controlled design and the comprehensive follow-up using validated scar assessment tools.
Limitations include:
Small sample size
Long-term follow up limited to 6mo
Average age was 75 yr; do results apply to younger population?
Future Directions
Studies need to evaluate if these results are generalizable to younger patients
Consider hybrid approaches (i.e. Integra then FTSG)
Clinical Relevance
The findings suggest a less invasive (and presumably less costly) approach may yield better cosmetic outcomes in elderly patients with small (3x3 cm), superficial ablative wounds of the tip or alae




Comments